Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

17 November 2026 : Original article  

Return to Alcohol Use After Liver Transplant: Who Is at Risk?

Sienna D. Lila BCDEF 1*, Kelly C. Hsu BC 2, Katherine C. Specht ORCID logo AB 3, Maria P. Diaz Soto AB 4, Eric M. Przybyszewski AB 5, Ana Ivkovic ABCD 6, Mladen Nisavic ABCD 6, Wei Zhang ABCDE 5, Leigh Anne Dageforde ABCDE 7, Sofia G. Baptista ORCID logo AB 8, Heidi Yeh ABCDE 8, Emily Bethea ORCID logo ABCDEF 5

DOI: 10.12659/AOT.952998

Ann Transplant 2026; 31:e952998

Abstract

0:00

BACKGROUND: Alcohol-associated liver disease remains the leading indication for liver transplant (LT), yet there has been limited analysis of what psychosocial factors correlate with biomarker-confirmed return to alcohol use in the post-LT setting.

MATERIAL AND METHODS: We conducted a single-center, retrospective, cohort study of all adult patients with alcohol-associated liver disease who received a liver transplant (LT) between 2016 and 2022. Medical records were queried for demographics, psychosocial variables, pre-LT sobriety duration, and 1-year post-LT mortality. Logistic regression and time-to-event analysis was used to correlate these factors with post-LT biomarker-confirmed return to alcohol use, defined as at least 1 positive urine ethyl glucuronide, urine ethyl sulfate, or serum phosphatidylethanol.

RESULTS: Of 194 LT recipients, 52 (27% of all patients, 42% of those tested) tested positive for 1 or more alcohol biomarkers at least once. Female sex and younger age, but not pre-LT sobriety duration, were identified as independent risk factors for biomarker-confirmed post-LT return to alcohol use. Survival analysis identified a shorter time to biomarker confirmed return to alcohol use for patients with <6 months (P<0.0001) and 6-12 months (P<0.0001) of pre-LT sobriety, compared with those with ≥12 months sobriety. However, patients with shorter pre-LT sobriety duration underwent biomarker testing significantly earlier following LT (P<0.0001). There was no difference in 1-year post-LT mortality between patients with <6 months and those with > 6-month pre-LT sobriety.

CONCLUSIONS: In this retrospective cohort study, we observed that 1-year mortality and biomarker-confirmed return to alcohol use outcomes were not affected by pre-LT sobriety duration, supporting evolving standards that favor individualized risk assessment over fixed abstinence periods.

Keywords: Alcohol Abstinence, Alcohol Drinking, Alcohol-Related Disorders, biomarkers, Liver, Mortality, Transplantation

Add Comment 0 Comments

Most Viewed Current Articles

24 Aug 2021 : Review article   22,545

Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future Perspectives

DOI :10.12659/AOT.931664

Ann Transplant 2021; 26:e931664

29 Sep 2015 : Review article   18,912

Risk Factors for Chronic Renal Insufficiency Following Cardiac Transplantation

DOI :10.12659/AOT.893788

Ann Transplant 2015; 20:576-587

29 Dec 2021 : Original article   18,710

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

22 Nov 2022 : Original article   17,291

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358